Enhabit (EHAB) to Release Quarterly Earnings on Wednesday

Enhabit (NYSE:EHAB) is set to issue its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of $0.05 per share for the quarter. Enhabit has set its FY 2024 guidance at 0.120-0.430 EPS.Investors that are interested in participating in the company’s conference call can do so using this link.

Enhabit (NYSE:EHAB) last issued its earnings results on Wednesday, March 6th. The company reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of $0.02 by $0.01. The firm had revenue of $260.60 million during the quarter, compared to analyst estimates of $260.30 million. Enhabit had a negative net margin of 7.69% and a positive return on equity of 1.55%. During the same quarter in the prior year, the business earned $0.32 earnings per share. On average, analysts expect Enhabit to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Enhabit Price Performance

Enhabit stock opened at $10.10 on Wednesday. The company has a market cap of $506.62 million, a price-to-earnings ratio of -6.23, a PEG ratio of 1.54 and a beta of 1.96. The firm’s fifty day moving average is $10.31 and its 200 day moving average is $9.96. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.76. Enhabit has a 52-week low of $7.12 and a 52-week high of $14.59.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on EHAB. UBS Group upgraded shares of Enhabit from a “sell” rating to a “neutral” rating and set a $9.50 target price on the stock in a report on Thursday, March 7th. Oppenheimer reiterated a “market perform” rating on shares of Enhabit in a research note on Thursday, March 7th. Finally, Jefferies Financial Group decreased their target price on shares of Enhabit from $15.00 to $14.00 and set a “buy” rating for the company in a research note on Wednesday, March 6th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, Enhabit has an average rating of “Hold” and a consensus price target of $12.08.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.